Tag Archives: 2022

PervasID to Present Solution for Tracking Medical Equipment and Surgical Instruments at Electronic and Biomedical Engineering Expo 2022

Company to exhibit and deliver presentation on solution which enhances decontamination, increases sterilisation processes, ensures mission-critical medical devices are available at the right place and time, for robust and efficient care saving billions of pounds across the NHS Cambridge, UK – Friday 24th June 2022 – PervasID, the company providing best-in-class battery-free Radio Frequency IDentification… Read More »

BI4ALL focuses on internationalisation and expects to grow 35% by 2022

For 2022, the company forecasts are for growth in the order of 35%, with higher expression in the international market. Lisbon, June 22nd, 2022 – BI4ALL, a leading Data Analytics and Artificial Intelligence services company, announces that is working hard on its international expansion plan and will open later this year a subsidiary in Switzerland,… Read More »

CIVIS Media Prize 2022 | eight programmes honoured – documentary receives TOP AWARD

03.06.2022 – Cologne (ots) | The winners of the European CIVIS Media Prize for Integration and Cultural Diversity 2022 have been announced: The main prize of 15,000 euros, the CIVIS TOP AWARD, goes to the documentary film Schwarze Adler (Black Eagles) (Amazon Prime Video | BROADVIEW | ZDF), by author and director Torsten Körner. The… Read More »

AdaptiveMobile Security, an Enea Company, Wins Best Mobile Authentication and Security Solution Award at GLOMO Awards 2022

AdaptiveMobile Security recognised for World’s First 5G Network Security Solution at MWC22 Barcelona 2nd March 2022, Barcelona This week, AdaptiveMobile Security, an Enea Company, was presented with the Best Mobile Authentication and Security Solution Award at the 2022 Global Mobile (GLOMO) Awards at MWC22 Barcelona. The Award, which recognises AdaptiveMobile Security for the World’s First… Read More »

Moderna aims for 3 billion doses in 2022

Drug manufacturer Moderna says it is boosting capacity to make its COVID-19 vaccine and expects to make up to 3 billion doses in 2022, more than twice its previous forecast. It also said it is increasing its expectations for 2021 vaccine production to between 800 million and 1 billion shots, raising the bottom of its… Read More »